Seeing Is Believing

Currently out of the existing stock ratings of Raymond Myers, 8 are a BUY (100%).
Analyst Raymond Myers, carries an average stock price target met ratio of 100% that have a potential upside of 29.63% achieved within 211 days. Previously, Raymond Myers worked at BENCHMARK.
Raymond Myers’s has documented 22 price targets and ratings displayed on 5 stocks. The coverage was on Healthcare, Consumer Cyclical sectors.
Most recent stock forecast was given on HSKA, Heska at 07-May-2018.
Analyst best performing recommendations are on EXAS (EXACT SCIENCES).
The best stock recommendation documented was for EXAS (EXACT SCIENCES) at 10/31/2017. The price target of $60 was fulfilled within 7 days with a profit of $5.01 (9.11%) receiving and performance score of 13.02.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Hold Since 24-Mar-2026
$85
3 months 20 days ago
(24-Mar-2026)
51/51 (100%)
$15.41 (22.14%)
294
Buy Since 10-Apr-2025
$105
$-1714.87 (-94.23%)
$85
5 months 24 days ago
(20-Jan-2026)
3/3 (100%)
$2.65 (2.59%)
89
Buy Since 03-Aug-2021
$105
$-1714.87 (-94.23%)
$68
6 months 9 days ago
(05-Jan-2026)
10/10 (100%)
$3.39 (3.34%)
392
Buy Since 09-Jul-2021
$105
$-1714.87 (-94.23%)
$75
7 months 19 days ago
(25-Nov-2025)
16/16 (100%)
$3.87 (3.83%)
607
Buy Since 31-May-2013
$85
7 months 20 days ago
(24-Nov-2025)
20/20 (100%)
$30.28 (55.34%)
240
What Year was the first public recommendation made by Raymond Myers?